Abstract:Evaluation of the zoonotic risk of animal SARSr-CoVs is important for future disease preparedness. However, there are misconceptions regarding the risk of animal viruses. ABSTRACT In the last 2 decades, pathogens originating in animals may have triggered three coronavirus pandemics, including the coronavirus disease 2019 pandemic. Thus, evaluation of the spillover risk of animal severe acute respiratory syndrome (SARS)-related coronavirus (SARSr-CoV) is important in the context of future disease preparedness. However, there is no analytical framework to assess the spillover risk of SARSr-CoVs, which cannot be determined by sequence analysis alone. Here, we established an integrity framework to evaluate the spillover risk of an animal SARSr-CoV by testing how viruses break through key human immune barriers, including viral cell tropism, replication dynamics, interferon signaling, inflammation, and adaptive immune barriers, using human ex vivo lung tissues, human airway and nasal organoids, and human lung cells. Using this framework, we showed that the two pre-emergent animal SARSr-CoVs, bat BtCoV-WIV1 and pangolin PCoV-GX, shared similar cell tropism but exhibited less replicative fitness in the human nasal cavity or airway than did SARS-CoV-2. Furthermore, these viruses triggered fewer proinflammatory responses and less cell death, yet showed interferon antagonist activity and the ability to partially escape adaptive immune barriers to SARS-CoV-2. Collectively, these animal viruses did not fully adapt to spread or cause severe diseases, thus causing successful zoonoses in humans. We believe that this experimental framework provides a path to identifying animal coronaviruses with the potential to cause future zoonoses. IMPORTANCE Evaluation of the zoonotic risk of animal SARSr-CoVs is important for future disease preparedness. However, there are misconceptions regarding the risk of animal viruses. For example, an animal SARSr-CoV could readily infect humans. Alternately, human receptor usage may result in spillover risk. Here, we established an analytical framework to assess the zoonotic risk of SARSr-CoV by testing a series of virus-host interaction profiles. Our data showed that the pre-emergent bat BtCoV-WIV1 and pangolin PCoV-GX were less adapted to humans than SARS-CoV-2 was, suggesting that it may be extremely rare for animal SARSr-CoVs to break all bottlenecks and cause successful zoonoses.

Comparative analysis of single cell lung atlas of bat, cat, tiger and pangolin

Comparative analysis of single cell lung atlas of bat, cat, tiger, and pangolin

Functional comparison of SARS-CoV-2 with closely related pangolin and bat coronaviruses

Single-cell transcriptional atlas of the Chinese horseshoe bat (Rhinolophus sinicus) provides insight into the cellular mechanisms which enable bats to be viral reservoirs

Molecular Characterization of Rig-I, Stat-1 and Ifn-Beta in the Horseshoe Bat

ACE2 receptor usage reveals variation in susceptibility to SARS-CoV and SARS-CoV-2 infection among bat species

Panoramic analysis of coronaviruses carried by representative bat species in Southern China to better understand the coronavirus sphere

Analogous comparison unravels heightened antiviral defense and boosted viral infection upon immunosuppression in bat organoids

Systematic Tracing of Susceptible Animals to SARS-CoV-2 by a Bioinformatics Framework

Virome survey of the bat, Rhinolophus affinis , in Hainan Province, China

Individual bat virome analysis reveals co-infection and spillover among bats and virus zoonotic potential

Isolation and Characterization of a Bat SARS-like Coronavirus That Uses the ACE2 Receptor

Comparative susceptibility of SARS-CoV-2, SARS-CoV, and MERS-CoV across mammals

Individual Bat Viromes Reveal the Co-Infection, Spillover and Emergence Risk of Potential Zoonotic Viruses

Prevalence and Genetic Diversity of Coronaviruses in Bats from China.

Strategy to Assess Zoonotic Potential Reveals Low Risk Posed by SARS-Related Coronaviruses from Bat and Pangolin

Angiotensin-converting enzyme 2 (ACE2) proteins of different bat species confer variable susceptibility to SARS-CoV entry

Differential prevalence and risk factors for infection with coronaviruses in bats collected during 2020 in Yunnan Province, China

Comparative Proteomics and Interactome Analysis of the SARS-CoV-2 Nucleocapsid Protein in Human and Bat Cell Lines

Genomic Characterization of Diverse Bat Coronavirus HKU10 in Hipposideros Bats.

Virome analysis for identification of novel mammalian viruses in bats from Southeast China